ANI Pharmaceuticals (ANIP)
(Real Time Quote from BATS)
$62.55 USD
+1.23 (2.01%)
Updated May 28, 2024 02:06 PM ET
4-Sell of 5 4
B Value A Growth F Momentum A VGM
Brokerage Reports
0 items in cart
ANI Pharmaceuticals, Inc. [ANIP]
Reports for Purchase
Showing records 81 - 88 ( 88 total )
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
4Q13 Upside Should Continue into 2014; PT to $33
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ANI Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Profitable Emerging Generic Company with Room to Grow
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S